跳至主要内容
临床试验/NCT04397406
NCT04397406已完成4 期

Role of Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor: A Double Blind Randomized Controlled Study

Tanta University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年7月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Duration of maternal analgesia

研究概览

简要总结

Central neuraxial analgesia has been extensively used for labor analgesia and is currently the gold standard technique for pain control in obstetrics.

The aim of the study will be to compare the role of dexmedetomidine or fentanyl as additives to epidural levobupivacaine in painless vaginal delivery as regard maternal analgesia and safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 41 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status class II and III,
  • Full term pregnancy.

排除标准

  • Patient refusal to epidural analgesia,
  • Contraindications of epidural analgesia (coagulopathy, local infection, vertebral deformity hypersensitivity to levobupivacaine, dexmedetomidine or fentanyl, hemodynamic instability, severe aortic or mitral stenosis),
  • Cardiac diseases
  • Severe pre-eclampsia,
  • Breech presentations
  • Antepartum hemorrhage
  • Cephalopelvic disproportion
  • Body mass index ≥40 kg/m2.

研究组 & 干预措施

Group D (Dexmedetomidine group)

Experimental

Epidural analgesia with levobupivacaine and dexmedetomidine

干预措施: Dexmedetomidine (Drug)

Group C (Control group)

Active Comparator

pidural analgesia with levobupivacaine alone

干预措施: levobupivacaine (Drug)

Group D (Dexmedetomidine group)

Experimental

Epidural analgesia with levobupivacaine and dexmedetomidine

干预措施: levobupivacaine (Drug)

Group F (Fentanyl group)

Experimental

Epidural analgesia with levobupivacaine and fentanyl

干预措施: levobupivacaine (Drug)

Group F (Fentanyl group)

Experimental

Epidural analgesia with levobupivacaine and fentanyl

干预措施: Fentanyl (Drug)

结局指标

主要结局

Duration of maternal analgesia

时间窗: 24 hours after epidural injection

Duration of analgesia will be assessed by measuring the time between the onset of sensory block and return of pain sensation. If the block is inadequate or the patient has pain, a top up dose of 8 mL of the study medication and local anesthetic will be given when visual analogue scale (VAS) will be ≥ 4. The pain relief will be assessed by the visual analogue scale (VAS) from 0 to 10 (0: no pain, 1-3: mild pain, 4-7: moderate pain, \> 7: severe pain).

次要结局

  • Onset of maternal analgesia.(One hour after epidural injection)
  • Complications of drugs of epidural technique(24 hours after epidural injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hend Mahmoud Moneeb El-shazly

Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验